Glenmark Life Q4 results: Net profit dips 33% to ₹98 crore, revenue declines to ₹536 crore

For the year ending March 31, 2024, the company reported a net profit of ₹471 crore as against ₹467 crore in the year-ago period, it said. "We concluded the financial year on a positive note with revenue growth of 5.6% on a full year basis, driven by regulated markets in external business," Glenmark Life Sciences MD & CEO Yasir Rawjee said.

The company's commitment to high-quality, innovative solutions and scalability will fuel sustainable long-term growth, he added. "These, coupled with a strong order book and demand visibility will ensure steady growth in FY25 and beyond," Rawjee said. Shares of the company closed 6.2% down at ₹775 apiece on the NSE.

The news is directly taken from news agency PTI's feed